XML 21 R11.htm IDEA: XBRL DOCUMENT v3.25.1
Discontinued Operations and Disposal Groups
 3 Months Ended
Mar. 31, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Disposal Groups, Including Discontinued Operations, Disclosure Discontinued Operations
In November 2024, we sold our tissue operations. The results of our tissue operations have been classified as discontinued operations in our Consolidated Statements of Operations for all periods presented. Amounts included below for the quarter ended March 31, 2025 consist of the settlement of contractual and employment related obligations that are directly related to the disposal. The following table presents the financial results of the tissue segment for the quarter ended March 31, 2025 and 2024:
 Quarter Ended March 31,
20252024
Net sales$— $253.1 
Cost of sales0.4 197.9 
Selling, general and administrative expenses0.1 7.7 
Depreciation and amortization— 13.9 
Other operating charges, net1.0 2.0 
Income (loss) from discontinued operations(1.5)31.6 
Other non-operating expense— (5.3)
   Total non-operating expense— (5.3)
Income (loss) from discontinued operations before income taxes(1.5)26.3 
Income tax benefit (provision)1.1 (6.9)
Income (loss) from discontinued operations, net of tax$(0.4)$19.3 
The major components of “Other operating charges, net” included in discontinued operations for the quarter ended March 31, 2025 and 2024 are reflected in the table below.
Quarter Ended March 31,
20252024
Divestiture related costs$1.0 $1.8 
Loss on sale or impairment associated with assets— 0.2 
$1.0 $2.0 

Operating and investing cash flows of the discontinued operation are presented in the following table:
 Quarter Ended March 31,
20252024
Net cash provided by (used in) operating activities of discontinued operations$(0.7)$56.2 
Net cash used in investing activities of discontinued operations— (3.7)
Additionally, we have not finalized the working capital adjustment with the buyer and therefore have accrued an estimate in "Accounts payable and accrued liabilities" included on our Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024.